G. Erfan, “Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors”, Acta Derm Venereol, vol. 97, no. 2, pp. 258–260, Sep. 2016.